Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2026-01-13 @ 7:06 PM
Study NCT ID:
NCT04346108
Status:
COMPLETED
Last Update Posted:
2024-03-22
First Post:
2020-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)
Sponsor:
Baxalta now part of Shire
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TAK-664-3001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None